Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

MEA115661: A Multi-centre, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects who participated in the MEA115588 or MEA115575 trials
mepolizumab
MEA115661
NCT01842607
Asthma
Phase 3
 
This is a follow-up study to MEA115588 and MEA115575. This study is available in CDISC format
November 2016

Powered by ideaPoint, Inc.